HydRegen Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $7.97M

  • Investors
  • 13

HydRegen General Information

Description

Developer of bio-based manufacturing technologies designed to make clean, safe, and sustainable chemicals. The company utilizes biocatalysis, which offers agility, speed, and predictability at an early stage in industrial research and development, enabling the chemicals and pharmaceutical sectors to validate that they meet critical cost, productivity, and reproducibility requirements on a large scale.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30 Upper High Street
  • Thame OX9 3EZ
  • England, United Kingdom
+44 01865
Primary Industry
Industrial Chemicals
Corporate Office
  • 30 Upper High Street
  • Thame OX9 3EZ
  • England, United Kingdom
+44 01865

HydRegen Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HydRegen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A1) 14-Oct-2026 $7.97M Completed Generating Revenue
5. Early Stage VC 31-Mar-2023 Completed Generating Revenue
4. Early Stage VC 13-Jan-2022 Completed Generating Revenue
3. Early Stage VC 31-Mar-2021 Completed Generating Revenue
2. Grant 01-Feb-2021 $573K Completed Generating Revenue
1. University Spin-Out 03-Dec-2020 Completed Startup
To view HydRegen’s complete valuation and funding history, request access »

HydRegen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 Preferred
Series A1 Preferred
A Ordinary
Ordinary 23,432 $0.000013 $21.82 $21.82 1x $21.82 6.79%
Ordinary 21,307 $0.000013 $19.93 $19.93 1x $19.93 6.18%
To view HydRegen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HydRegen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HydRegen Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
First Imagine! Ventures Venture Capital Minority
Foxglove Capital Merchant Banking Firm Minority
Genoa Ventures Venture Capital Minority
Headington Holdings Corporation Minority
Oxonian Investment PE/Buyout Minority
You’re viewing 5 of 13 investors. Get the full list »

HydRegen FAQs

  • When was HydRegen founded?

    HydRegen was founded in 2020.

  • Where is HydRegen headquartered?

    HydRegen is headquartered in Thame, United Kingdom.

  • What is the size of HydRegen?

    HydRegen has 18 total employees.

  • What industry is HydRegen in?

    HydRegen’s primary industry is Industrial Chemicals.

  • Is HydRegen a private or public company?

    HydRegen is a Private company.

  • What is the current valuation of HydRegen?

    The current valuation of HydRegen is .

  • What is HydRegen’s current revenue?

    The current revenue for HydRegen is .

  • How much funding has HydRegen raised over time?

    HydRegen has raised $12M.

  • Who are HydRegen’s investors?

    First Imagine! Ventures, Foxglove Capital, Genoa Ventures, Headington Holdings, and Oxonian Investment are 5 of 13 investors who have invested in HydRegen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process